Meningococcal Group B Vaccine Dosage
Medically reviewed by Drugs.com. Last updated on Sep 30, 2024.
Applies to the following strengths: fully recombinant; recombinant, OMV, adjuvanted
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Meningitis - Meningococcal
PATIENTS UP TO 25 YEARS OLD:
Two-dose schedule: 0.5 mL IM once, administered at 0 and 6 months
- If the second dose is given less than 6 months after the first dose, a third dose should be given at least 4 months after the second dose
Three-dose schedule: 0.5 mL IM once, administered at 0, 1 to 2, and 6 months
Comments:
- The dosing schedule should be determined by the patient's risk of exposure and the susceptibility to the disease.
- The dosage schedules for Bexsero and Trumenba are the same; however, it is not known if the vaccines are interchangeable.
Use: Active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B
Usual Pediatric Dose for Meningitis - Meningococcal
PATIENTS 10 YEARS AND OLDER:
Two-dose schedule: 0.5 mL IM once, administered at 0 and 6 months
- If the second dose is given less than 6 months after the first dose, a third dose should be given at least 4 months after the second dose
Three-dose schedule: 0.5 mL IM once, administered at 0, 1 to 2, and 6 months
Comments:
- The dosing schedule should be determined by the patient's risk of exposure and the susceptibility to the disease.
- The dosage schedules for Bexsero and Trumenba are the same; however, it is not known if the vaccines are interchangeable.
Use: Active immunization to prevent invasive disease caused by N meningitidis serogroup B
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- Known history of severe allergic reactions (e.g., anaphylaxis) to the active component or any of the ingredients
- History of a severe allergic reaction after a previous dose of this vaccine
Safety and efficacy have not been established in patients younger than 10 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Administer IM in the deltoid muscle of the upper arm.
Storage requirements:
- Store refrigerated between 2C to 8C (36F to 26F); protect from light.
- Do not freeze. Discard if the vaccine has been frozen.
Reconstitution/preparation techniques:
- Shake vigorously to ensure a homogenous suspension.
- Do not use if the vaccine cannot be resuspended.
Reconstitution/preparation techniques:
- Do not dilute.
- Consult the Fact Sheet for Health Care Providers.
Patient advice:
- To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS): https://vaers.hhs.gov
More about meningococcal group B vaccine
- Check interactions
- Compare alternatives
- Reviews (3)
- Side effects
- During pregnancy
- Drug class: bacterial vaccines
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Rocephin
Rocephin (ceftriaxone) is used to treat bacterial infections, including severe or life-threatening ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rifadin
Rifadin is used for bartonellosis, endocarditis, haemophilus influenzae prophylaxis, legionella ...
Minocin
Minocin is used for acne, actinomycosis, bacterial infection, bullous pemphigoid, meningitis ...
Menactra
Menactra is used to prevent infection caused by meningococcal bacteria. Learn about side effects ...
Menveo
Menveo (meningococcal conjugate vaccine) is used to prevent infection caused by meningococcal ...
Trumenba
Trumenba is used for meningitis, meningococcal, meningococcal disease prophylaxis
Bexsero
Bexsero is used for meningitis, meningococcal, meningococcal disease prophylaxis
Meningococcal conjugate vaccine
Meningococcal conjugate vaccine systemic is used for meningococcal disease prophylaxis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.